MedPath

Effect of garlic on some types of adipokines in metabolic syndrome

Not Applicable
Conditions
Metabolic Syndrome.
E65-E68
E00-E90
Registration Number
IRCT138706121179N1
Lead Sponsor
Zanjan Metabolic Diseases Research Center, Zanjan university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

All people who will be diagnosed to have metabolic syndrome based on ATPIII criteria , more than 18 years old. Exclusion criteria: Presence of acute or chronic inflammatory or infectious diseases, taking anti inflammatory medications or other drugs affecting insulin resistance.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum Adiponectin. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: ELISA.;Serum TNF. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: ELISA.;Serum IL6. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
Serum lipid Concentrations(TG, Cholesterol, HDL-C). Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: Enzymatic methods.;Fasting Plasma Glucose. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: Enzymatic methods.;Blood pressure. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: standard methods for BP.;Waist circomferance. Timepoint: at the begining of the study and 6weeks after intervention. Method of measurement: standard methods.
© Copyright 2025. All Rights Reserved by MedPath